Clinical Trial Update: Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating treatment for Mycobacterium avium complex infection in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Mycobacterium Avium Complex Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mycobacterium Avium-intracellulare Infection, HIV Infections | Phase 2 | Status: COMPLETED